Back
Bicycle Therapeutics PLC Stock Predictions
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
BCYC
Bicycle Therapeutics PLC
Last Price:
$10.00
Seasonality Move:
-7.52%
7 Day Trial
ALL ACCESS PASS
$
7
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Bicycle Therapeutics PLC Stock Forecast
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 4.9% based on the past 5 years of stock performance.
-
Bicycle Therapeutics PLC has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Bicycle Therapeutics PLC Stock Undervalued?The current Bicycle Therapeutics PLC [BCYC] share price is $9.65. The Score for BCYC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
BCYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Bicycle Therapeutics PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 4.9% based on the past 5 years of stock performance.
Bicycle Therapeutics PLC Stock Rating
Sell
20
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC overpriced?
-
Bicycle Therapeutics PLC has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Bicycle Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bicycletherapeutics.com
52-Week Data
52-Week High:
28.67
52-Week Low:
9.41
Prediction Charts
Market Cap:
667.8M
Price in USD:
9.65
Volume:
628.9K
Beta:
0.87
Technical Analysis
SMA50:
12.55
SMA100:
16.90
SMA200:
19.91
52-Wk Change:
-57.93%
Stock Predictions
-
Is Bicycle Therapeutics PLC stock public?Yes, Bicycle Therapeutics PLC is a publicly traded company.
-
What is the Bicycle Therapeutics PLC stock quote today?The Bicycle Therapeutics PLC stock price is 9.65 USD today.
-
How to buy Bicycle Therapeutics PLC stock online?You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-21 | 12.05 | 11.66 | 12.61 | 11.62 |
| Feb-25 | 11.25 | 11.11 | 11.48 | 10.91 |
| Feb-26 | 11.09 | 11.32 | 11.79 | 11.09 |
| Feb-27 | 11.44 | 11.03 | 11.62 | 11.00 |
| Feb-28 | 10.95 | 10.97 | 11.12 | 10.81 |
| Mar-3 | 10.92 | 10.47 | 11.16 | 10.38 |
| Mar-4 | 10.36 | 10.14 | 10.67 | 10.07 |
| Mar-5 | 10.15 | 10.38 | 10.62 | 9.99 |
| Mar-6 | 10.27 | 10.65 | 10.72 | 10.00 |
| Mar-7 | 10.59 | 10.23 | 10.89 | 10.18 |
| Mar-11 | 9.78 | 10.21 | 10.38 | 9.60 |
| Mar-12 | 10.33 | 10.40 | 10.84 | 10.30 |
| Mar-13 | 10.44 | 9.63 | 10.59 | 9.59 |
| Mar-14 | 9.77 | 9.65 | 10.32 | 9.41 |
Bicycle Therapeutics PLC Earnings
Bicycle Therapeutics PLC Earnings Report: Per Share Bicycle Therapeutics PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bicycle Therapeutics PLC Forecast Revenue Growth
Bicycle Therapeutics PLC Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.27 per share, and a decrease next year of $0.56 per share.
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.